A detailed history of Pdt Partners, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Pdt Partners, LLC holds 89,267 shares of WVE stock, worth $740,023. This represents 0.05% of its overall portfolio holdings.

Number of Shares
89,267
Previous 13,300 571.18%
Holding current value
$740,023
Previous $82,000 442.68%
% of portfolio
0.05%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$4.38 - $6.48 $332,735 - $492,266
75,967 Added 571.18%
89,267 $445,000
Q1 2024

May 15, 2024

BUY
$3.54 - $6.84 $47,082 - $90,972
13,300 New
13,300 $82,000
Q1 2021

May 17, 2021

SELL
$5.61 - $12.01 $732,666 - $1.57 Million
-130,600 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$6.99 - $9.26 $494,892 - $655,608
70,800 Added 118.39%
130,600 $1.03 Million
Q3 2020

Nov 16, 2020

SELL
$8.49 - $19.54 $517 - $1,191
-61 Reduced 0.1%
59,800 $508,000
Q2 2020

Aug 14, 2020

SELL
$7.44 - $11.29 $433,298 - $657,518
-58,239 Reduced 49.31%
59,861 $623,000
Q1 2020

May 15, 2020

BUY
$6.94 - $14.22 $432,362 - $885,906
62,300 Added 111.65%
118,100 $1.11 Million
Q4 2019

Feb 14, 2020

BUY
$7.99 - $37.6 $95,880 - $451,200
12,000 Added 27.4%
55,800 $447,000
Q3 2019

Nov 14, 2019

SELL
$19.17 - $27.4 $147,609 - $210,980
-7,700 Reduced 14.95%
43,800 $899,000
Q2 2019

Aug 14, 2019

BUY
$22.93 - $42.84 $649,148 - $1.21 Million
28,310 Added 122.08%
51,500 $1.34 Million
Q1 2019

May 15, 2019

BUY
$32.69 - $47.91 $231,772 - $339,681
7,090 Added 44.04%
23,190 $901,000
Q4 2018

Feb 14, 2019

SELL
$37.1 - $50.11 $197,223 - $266,384
-5,316 Reduced 24.82%
16,100 $677,000
Q3 2018

Nov 14, 2018

SELL
$36.35 - $55.2 $598,902 - $909,475
-16,476 Reduced 43.48%
21,416 $1.07 Million
Q2 2018

Aug 14, 2018

SELL
$33.85 - $50.65 $237,220 - $354,955
-7,008 Reduced 15.61%
37,892 $1.45 Million
Q1 2018

May 15, 2018

BUY
$32.45 - $54.7 $1.46 Million - $2.46 Million
44,900 New
44,900 $1.8 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $720M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.